CD8 (2.43) Antibody sc-18860 from Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

(1) PAK4 Is Involved in the Stabilization of PD-L1 and the Resistance to Doxorubicin in Osteosarcoma and Predicts the Survival of Diagnosed PatientsCellsAugust 28, 2024Junyue Zhang, Yiping Song, Ae-Ri Ahn, Ho Sung Park, See-Hyoung Park, Young Jae Moon, Kyoung Min Kim, Kyu Yun JangSan Diego, CA, USA), CD4 (#sc20079, 1:100, Santa Cruz Biotechnology, Santa Cruz, CA, USA), and CD8 (#sc-18860, 1:100, Santa Cruz Biotechnology, Santa Cruz, CA, USA) overnight at 4 °C. Thereafter, the following

(2) Trim-Away in adult animals through Nano-ERASER and its application in cancer therapyResearch squareJanuary 17, 2023Wang M, Wang J, Wang Y, Raja MK, Gupta G, Hu X, Shi S, Chen H, Fan D, Xu P.

(5) Alfalfa mosaic virus nanoparticles-based in situ vaccination induces antitumor immune responses in breast cancer modelNanomedicine (London, England)January 1, 2021Shahgolzari M, Pazhouhandeh M, Milani M, Fiering S, Khosroushahi AY.

(6) B(1) and B(2) kinin receptor blockade improves psoriasis-like diseaseBritish journal of pharmacologyAugust 1, 2020Soley BDS, Silva LM, Mendes DAGB, Báfica A, Pesquero JB, Bader M, Witherden DA, Havran WL, Calixto JB, Otuki MF, et al.

(8) Modulatory effects of levamisole and garlic oil on the immune response of Wistar rats: Biochemical, immunohistochemical, molecular and immunological studyMolecular medicine reportsSeptember 1, 2016Mohamed EH, Baiomy AA, Ibrahim ZS, Soliman MM.purchased from Qiagen, Inc. (Valencia, CA, USA). Anti‑rat CD4 (cat. no. sc‑7219) and CD8 (cat. no. sc‑18860) primary antibodies were purchased from Santa Cruz Biotechnology, Inc. (Dallas, TX, USA). Animals, experimental design

(9) Enhancing Dendritic Cell-based Immunotherapy with IL-2/Monoclonal Antibody Complexes for Control of Established TumorsJournal of immunology (Baltimore, Md. : 1950)November 1, 2015Kim MT, Richer MJ, Gross BP, Norian LA, Badovinac VP, Harty JT.

(13) Insulin-like growth factor-binding protein-2 is a target for the immunomodulation of breast cancerCancer researchOctober 15, 2008Park KH, Gad E, Goodell V, Dang Y, Wild T, Higgins D, Fintak P, Childs J, Dela Rosa C, Disis ML.

(14) Antigen-specific responses accelerate bacterial clearance in the bladderJournal of immunology (Baltimore, Md. : 1950)March 1, 2006Thumbikat P, Waltenbaugh C, Schaeffer AJ, Klumpp DJ.

CD8 (2.43) Antibody